edoc

Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines

Mizukawa, Y. and Ikegami-Kawai, M. and Horiuchi, M. and Kaiser, M. and Kojima, M. and Sakanoue, S. and Miyagi, S. and Nanga Chick, C. and Togashi, H. and Tsubuki, M. and Ihara, M. and Usuki, T. and Itoh, I.. (2021) Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines. Bioorganic & medicinal chemistry, 33. p. 116018.

[img] PDF - Published Version
Available under License CC BY (Attribution).

910Kb

Official URL: https://edoc.unibas.ch/89261/

Downloads: Statistics Overview

Abstract

Quinazolines have long been known to exert varied pharmacologic activities that make them suitable for use in treating hypertension, viral infections, tumors, and malaria. Since 2014, we have synthesized approximately 150 different 6,7-dimethoxyquinazoline-2,4-diamines and evaluated their antimalarial activity via structure-activity relationship studies. Here, we summarize the results and report the discovery of 6,7-dimethoxy-N(4)-(1-phenylethyl)-2-(pyrrolidin-1-yl)quinazolin-4-amine (20, SSJ-717), which exhibits high antimalarial activity as a promising antimalarial drug lead.
Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Parasite Chemotherapy (Mäser)
UniBasel Contributors:Kaiser, Marcel
Item Type:Article, refereed
Article Subtype:Research Article
ISSN:0968-0896
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Related URLs:
Identification Number:
edoc DOI:
Last Modified:20 Dec 2022 14:48
Deposited On:20 Dec 2022 14:48

Repository Staff Only: item control page